1887

Journal of Medical Microbiology logo

Volume 71, Issue 5

Network-wide analysis of the Serosep EntericBio Gastro Panel 2 for the detection of enteric pathogens in Public Health Wales microbiology laboratories No Access

Abstract

A retrospective data analysis of 34 months (spanning 2016–2020) of 961573 diagnostic results obtained before and after nucleic acid amplification testing (NAAT) implementation, across the Public Health Wales microbiology network.

This is the first network-wide analysis of the implementation of enteric NAAT in diagnostic microbiology.

To assess the outcome of replacing microscopy and bacterial culture with NAAT as the primary test in the diagnosis of: spp. sp., spp. Shiga toxin-producing (STEC) spp. and infections.

Following NAAT introduction, bacterial culture was performed as a secondary test, to provide further information from NAAT positive samples for epidemiological purposes. Primary detection rates and overall bacterial culture rates were calculated for each target pathogen using both testing regimes (Stage I) including a comparison of in-patient and out-patient diagnoses (Stage II).

Stage I analysis showed that the primary detection rate significantly increased for spp. (<0.0001), sp. (=0.0151), spp. (<0.0001), STEC (<0.0001), spp. (<0.0001) and (<0.0001) when using NAAT compared to microscopy or bacterial culture. A significant decrease was seen in the overall rate of spp. isolation by bacterial culture (<0.0001), whilst other targets remained unaffected. Stage II analysis showed that NAAT positive out-patient samples were more likely to be supplemented by a positive bacterial culture than NAAT positive in-patient samples for spp. (<0.0001) sp. (=0.0004) and STEC (=0.0039). However, spp. was more frequently isolated from NAAT positive in-patient samples (=0.0005). A notable increase was seen for detection from in-patient samples (=0.0002). Reference laboratory data showed the NAAT assay can detect at least 53 serotypes of STEC but may not be able to detect some of the rarer species of seen in human infections.

The implementation of NAAT has significantly increased the primary detection rate of all target enteric pathogens in Wales and information gleaned previously from direct culture is largely unaffected.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): bacterial culture , Campylobacter , Cryptosporidium , diagnosis , Giardia , microscopy , NAAT , PCR , Salmonella , Shigella and STEC
© 2022 The Authors
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001555
2022-05-31
2024-05-12
Loading full text...

Full text loading...

References

  1. Lamps LW. Infectious disorders of the GI tract. In Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancrea Elsevier; 2009 pp 51–79
     [Google Scholar]
  2. Amjad M. An overview of the molecular methods in the diagnosis of gastrointestinal infectious diseases. Int J Microbiol 2020; 2020:8135724 [View Article] [PubMed]
     [Google Scholar]
  3. Sweetser S. Evaluating the patient with diarrhea: a case-based approach. Mayo Clin Proc 2012; 87:596–602 [View Article] [PubMed]
     [Google Scholar]
  4. Humphries RM, Linscott AJ. Practical guidance for clinical microbiology laboratories: diagnosis of bacterial gastroenteritis. Clin Microbiol Rev 2015; 28:3–31 [View Article] [PubMed]
     [Google Scholar]
  5. McAuliffe G, Bissessor L, Williamson D, Moore S, Wilson J et al. Use of the EntericBio Gastro Panel II in a diagnostic microbiology laboratory: challenges and opportunities. Pathology 2017; 49:419–422 [View Article] [PubMed]
     [Google Scholar]
  6. O’Leary J, Corcoran D, Lucey B. Comparison of the EntericBio multiplex PCR system with routine culture for detection of bacterial enteric pathogens. J Clin Microbiol 2009; 47:3449–3453 [View Article] [PubMed]
     [Google Scholar]
  7. Garcia LS, Arrowood M, Kokoskin E, Paltridge GP, Pillai DR et al. Practical guidance for clinical microbiology laboratories: laboratory diagnosis of parasites from the gastrointestinal tract. Clin Microbiol Rev 2018; 31:e00025-17 [View Article] [PubMed]
     [Google Scholar]
  8. UK Government Department of Infectious Diseases UK Standards for microbiology investigations S 7: gastroenteritis; 2013 https://www.gov.uk/government/publications/smi-s-7-gastroenteritis-and-diarrhoea
  9. Koziel M, Corcoran D, O’Callaghan I, Sleator RD, Lucey B. Validation of the EntericBio Panel II® multiplex polymerase chain reaction system for detection of Campylobacter spp., Salmonella spp., Shigella spp., and verotoxigenic E. coli for use in a clinical diagnostic setting. Diagn Microbiol Infect Dis 2013; 75:46–49 [View Article] [PubMed]
     [Google Scholar]
  10. Perry MD, Corden SA, Howe RA. Evaluation of the Luminex xTAG Gastrointestinal Pathogen Panel and the Savyon Diagnostics Gastrointestinal Infection Panel for the detection of enteric pathogens in clinical samples. J Med Microbiol 2014; 63:1419–1426 [View Article] [PubMed]
     [Google Scholar]
  11. Perry MD, Corden SA, Lewis White P. Evaluation of the BD MAX Enteric Parasite Panel for the detection of Cryptosporidium parvum/hominis, Giardia duodenalis and Entamoeba histolytica. J Med Microbiol 2017; 66:1118–1123 [View Article] [PubMed]
     [Google Scholar]
  12. EntericBio Gastro panel 2 user manual.EBRT 52 (rev 04).
  13. Kovats RS, Edwards SJ, Charron D, Cowden J, D’Souza RM et al. Climate variability and campylobacter infection: an international study. Int J Biometeorol 2005; 49:207–214 [View Article] [PubMed]
     [Google Scholar]
  14. Strachan NJC, Rotariu O, Smith-Palmer A, Cowden J, Sheppard SK et al. Identifying the seasonal origins of human campylobacteriosis. Epidemiol Infect 2013; 141:1267–1275 [View Article] [PubMed]
     [Google Scholar]
  15. Gradel KO, Dethlefsen C, Schønheyder HC, Ejlertsen T, Sørensen HT et al. Severity of infection and seasonal variation of non-typhoid Salmonella occurrence in humans. Epidemiol Infect 2007; 135:93–99 [View Article] [PubMed]
     [Google Scholar]
  16. Jagai JS, Castronovo DA, Monchak J, Naumova EN. Seasonality of cryptosporidiosis: A meta-analysis approach. Environ Res 2009; 109:465–478 [View Article] [PubMed]
     [Google Scholar]
  17. Brunn A, Fisman DN, Sargeant JM, Greer AL. The influence of climate and livestock reservoirs on human cases of giardiasis. Ecohealth 2019; 16:116–127 [View Article] [PubMed]
     [Google Scholar]
  18. Garvey P, Carroll A, McNamara E, Charlett A, Danis K et al. Serogroup-specific seasonality of verotoxigenic Escherichia coli, Ireland. Emerg Infect Dis 2016; 22:742–744 [View Article] [PubMed]
     [Google Scholar]
  19. Jenkins C, Lawson AJ, Cheasty T, Willshaw GA. Assessment of a real-time PCR for the detection and characterization of verocytotoxigenic Escherichia coli. J Med Microbiol 2012; 61:1082–1085 [View Article] [PubMed]
     [Google Scholar]
  20. Jenkins C, Perry NT, Godbole G, Gharbia S. Evaluation of chromogenic selective agar (CHROMagar STEC) for the direct detection of Shiga toxin-producing Escherichia coli from faecal specimens. J Med Microbiol 2020; 69:487–491 [View Article] [PubMed]
     [Google Scholar]
  21. Robinson G, Elwin K, Chalmers RM. Cryptosporidium diagnostic assays: molecular detection. Methods Mol Biol 2020; 2052:11–22
     [Google Scholar]
  22. Elwin K, Fairclough HV, Hadfield SJ, Chalmers RM. Giardia duodenalis typing from stools: a comparison of three approaches to extracting DNA, and validation of a probe-based real-time PCR typing assay. J Med Microbiol 2014; 63:38–44 [View Article] [PubMed]
     [Google Scholar]
  23. McAuliffe GN, Anderson TP, Stevens M, Adams J, Coleman R et al. Systematic application of multiplex PCR enhances the detection of bacteria, parasites, and viruses in stool samples. J Infect 2013; 67:122–129 [View Article] [PubMed]
     [Google Scholar]
  24. de Boer RF, Ott A, Kesztyüs B, Kooistra-Smid AMD. Improved detection of five major gastrointestinal pathogens by use of a molecular screening approach. J Clin Microbiol 2010; 48:4140–4146 [View Article] [PubMed]
     [Google Scholar]
  25. Laude A, Valot S, Desoubeaux G, Argy N, Nourrisson C et al. Is real-time PCR-based diagnosis similar in performance to routine parasitological examination for the identification of Giardia intestinalis, Cryptosporidium parvum/Cryptosporidium hominis and Entamoeba histolytica from stool samples? Evaluation of a new commercial multiplex PCR assay and literature review. Clin Microbiol Infect 2016; 22:190 [View Article] [PubMed]
     [Google Scholar]
  26. Khalil IA, Troeger C, Blacker BF, Rao PC, Brown A et al. Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990-2016. Lancet Infect Dis 2018; 18:1229–1240 [View Article] [PubMed]
     [Google Scholar]
  27. Croxen MA, Law RJ, Scholz R, Keeney KM, Wlodarska M et al. Recent advances in understanding enteric pathogenic Escherichia coli. Clin Microbiol Rev 2013; 26:822–880 [View Article] [PubMed]
     [Google Scholar]
  28. Alperi A, Figueras MJ. Human isolates of Aeromonas possess Shiga toxin genes (stx1 and stx2) highly similar to the most virulent gene variants of Escherichia coli. Clin Microbiol Infect 2010; 16:1563–1567 [View Article] [PubMed]
     [Google Scholar]
  29. Schmidt H, Montag M, Bockemühl J, Heesemann J, Karch H. Shiga-like toxin II-related cytotoxins in Citrobacter freundii strains from humans and beef samples. Infect Immun 1993; 61:534–543 [View Article] [PubMed]
     [Google Scholar]
  30. Khalil RKS, Skinner C, Patfield S, He X. Phage-mediated Shiga toxin (Stx) horizontal gene transfer and expression in non-Shiga toxigenic Enterobacter and Escherichia coli strains. Pathog Dis 2016; 74:ftw037 [View Article] [PubMed]
     [Google Scholar]
  31. Pennington TH. E. coli O157 outbreaks in the United Kingdom: past, present, and future. Infect Drug Resist 2014; 7:211–222 [View Article] [PubMed]
     [Google Scholar]
  32. Byrne L, Dallman TJ, Adams N, Mikhail AFW, McCarthy N et al. Highly pathogenic clone of shiga toxin-producing Escherichia coli O157:H7, England and Wales. Emerg Infect Dis 2018; 24:2303–2308 [View Article] [PubMed]
     [Google Scholar]
  33. Adams NL, Byrne L, Smith GA, Elson R, Harris JP et al. Shiga toxin-producing escherichia coli O157, england and wales, 1983-2012. Emerging Infect Dis 2016; 22:590–597
     [Google Scholar]
  34. Hart J, Smith G. Verocytotoxin-producing Escherichia coli O157 outbreak in Wrexham, North Wales, July 2009. Eurosurveillance 2009; 14: [View Article]
     [Google Scholar]
  35. Whittaker PJ, Sopwith W, Quigley C, Gillespie I, Willshaw GA et al. A national outbreak of verotoxin-producing Escherichia coli O157 associated with consumption of lemon-and-coriander chicken wraps from A supermarket chain. Epidemiol Infect 2009; 137:375–382 [View Article] [PubMed]
     [Google Scholar]
  36. Verma A, Bolton FJ, Fiefield D, Lamb P, Woloschin E et al. An outbreak of E. coli O157 associated with a swimming pool: an unusual vehicle of transmission. Epidemiol Infect 2007; 135:989–992 [View Article] [PubMed]
     [Google Scholar]
  37. Salmon R. Outbreak Control Team Outbreak of verotoxin producing E.coli O157 infections involving over forty schools in south Wales, September 2005. Euro Surveill 2005; 10:E051006 [View Article]
     [Google Scholar]
  38. Carroll KJ, Harvey-Vince L, Jenkins C, Mohan K, Balasegaram S. The epidemiology of Shiga toxin-producing Escherichia coli infections in the South East of England: November 2013-March 2017 and significance for clinical and public health. J Med Microbiol 2019; 68:930–939 [View Article] [PubMed]
     [Google Scholar]
  39. Byrne L, Vanstone GL, Perry NT, Launders N, Adak GK et al. Epidemiology and microbiology of Shiga toxin-producing Escherichia coli other than serogroup O157 in England, 2009-2013. J Med Microbiol 2014; 63:1181–1188 [View Article] [PubMed]
     [Google Scholar]
  40. Chalmers RM, Campbell BM, Crouch N, Charlett A, Davies AP. Comparison of diagnostic sensitivity and specificity of seven Cryptosporidium assays used in the UK. J Med Microbiol 2011; 60:1598–1604 [View Article] [PubMed]
     [Google Scholar]
  41. Koziel M, Kiely R, Blake L, O’Callaghan I, Corcoran GD et al. Improved detection of bacterial pathogens in patients presenting with gastroenteritis by use of the EntericBio real-time Gastro Panel I assay. J Clin Microbiol 2013; 51:2679–2685 [View Article] [PubMed]
     [Google Scholar]
  42. Khare R, Espy MJ, Cebelinski E, Boxrud D, Sloan LM et al. Comparative evaluation of two commercial multiplex panels for detection of gastrointestinal pathogens by use of clinical stool specimens. J Clin Microbiol 2014; 52:3667–3673 [View Article] [PubMed]
     [Google Scholar]
  43. Chaisowwong W, Kusumoto A, Hashimoto M, Harada T, Maklon K et al. Physiological characterization of Campylobacter jejuni under cold stresses conditions: its potential for public threat. J Vet Med Sci 2012; 74:43–50 [View Article] [PubMed]
     [Google Scholar]
  44. Buss JE, Thacker E, Santiago M. Culture methods to determine the limit of detection and survival in transport media of Campylobacter Jejuni in human fecal specimens. JoVE 2020; 2020:157 [View Article]
     [Google Scholar]
  45. Bullman S, Corcoran D, O’Leary J, Lucey B, Byrne D et al. Campylobacter ureolyticus: an emerging gastrointestinal pathogen?. FEMS Immunol Med Microbiol 2011; 61:228–230 [View Article] [PubMed]
     [Google Scholar]
  46. Man SM. The clinical importance of emerging Campylobacter species. Nat Rev Gastroenterol Hepatol 2011; 8:669–685 [View Article]
     [Google Scholar]
  47. Engberg J, On SL, Harrington CS, Gerner-Smidt P. Prevalence of Campylobacter, Arcobacter, Helicobacter, and Sutterella spp. in human fecal samples as estimated by a reevaluation of isolation methods for Campylobacters. J Clin Microbiol 2000; 38:286–291 [View Article] [PubMed]
     [Google Scholar]
  48. Lévesque S, Fournier E, Carrier N, Frost E, Arbeit RD et al. Campylobacteriosis in urban versus rural areas: a case-case study integrated with molecular typing to validate risk factors and to attribute sources of infection. PLoS One 2013; 8:e83731 [View Article] [PubMed]
     [Google Scholar]
  49. Domingues AR, Pires SM, Halasa T, Hald T. Source attribution of human salmonellosis using a meta-analysis of case-control studies of sporadic infections. Epidemiol Infect 2012; 140:959–969 [View Article] [PubMed]
     [Google Scholar]
  50. Friesema IHM, Kuiling S, Igloi Z, Franz E. Optimization of notification criteria for shiga toxin-producing Escherichia coli surveillance, the Netherlands. Emerg Infect Dis 2021; 27:258–261 [View Article] [PubMed]
     [Google Scholar]
  51. UK Government Department of Infectious Diseases Guidance updates on preventing person-to-person spread of gastrointestinal infections; 2004 https://www.gov.uk/government/publications/preventing-person-to-person-gastrointestinal-infections
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.001555
Loading
Network-wide analysis of the Serosep EntericBio Gastro Panel 2 for the detection of enteric pathogens in Public Health Wales microbiology laboratories
J. Med. Microbiol. 71, 001555 (2022); https://doi.org/10.1099/jmm.0.001555
/content/journal/jmm/10.1099/jmm.0.001555
/content/journal/jmm/10.1099/jmm.0.001555
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error